The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Genetic Analysis Market By The End Of 2030?
The genetic analysis market has experienced rapid expansion in recent years. It is projected to increase from $10.29 billion in 2025 to $11.63 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. The growth observed in the past can be ascribed to elements such as the restricted availability of high-throughput sequencing platforms, dependence on conventional genetic testing approaches, rising awareness of genetic disorders, increased investment in research laboratories, and a growing number of diagnostic centers.
The genetic analysis market is projected for substantial expansion over the coming years. This market is anticipated to reach $18.75 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to advancements in ngs and real-time pcr technologies, the development of cloud-based genomic data platforms, increasing adoption of personalized medicine, rising government initiatives for genetic disease screening, and the integration of ai and bioinformatics tools in diagnostics. Key trends anticipated within this period include the expansion of next-generation sequencing (ngs) and pcr-based genetic testing, growing adoption of pharmacogenomic testing for personalized medicine, an increase in prenatal and newborn genetic screening programs, a rising focus on rare disease and cancer genetic diagnostics, and the integration of bioinformatics and genomic data analysis tools.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27295&type=smp
Which Market Drivers Are Supporting The Expansion Of The Genetic Analysis Market?
The rising incidence of cancer is anticipated to propel the growth of the genetic analysis market. Cancer is defined as a disease where specific cells within the body multiply uncontrollably and have the potential to spread to other regions. The surge in cancer cases stems from an aging global population, as older individuals are more prone to accumulating genetic mutations and experiencing prolonged exposure to environmental and lifestyle risk factors that contribute to cancer development. Genetic analysis proves valuable in cancer management by identifying the exact genetic mutations responsible for the condition, thereby empowering doctors to select targeted treatments that are more effective and induce fewer side effects. For instance, in May 2025, a report from the National Cancer Institute (NCI), a US-based agency focused on cancer research and training, indicated that close to 20 million people worldwide received a new cancer diagnosis in 2022, and about 9.7 million tragically lost their lives to it. Forecasts suggest that by 2050, the annual count of new cancer cases could reach 33 million, with cancer deaths expected to increase to 18.2 million. Thus, the growing number of cancer cases is a key driver for the expansion of the genetic analysis market.
Which Segment Classifications Shape The Genetic Analysis Market?
The genetic analysis market covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments, Software
2) By Test: Predictive Genetic Testing, Carrier Testing, Prenatal And Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Other Tests
3) By Technology: Next-Generation Sequencing (NGS), Real-Time PCR System, Other Technologies
4) By Application: Cancer, Genetic Diseases, Cardiovascular Diseases, Rare Diseases, Infectious Diseases, Other Applications
5) By End-Use: Hospitals, Research And Development Laboratories, Diagnostic Centers, Other End-Uses
Subsegments:
1) By Reagents And Kits: DNA Extraction Kits, RNA Extraction Kits, PCR Reagents, Sequencing Reagents, Library Preparation Kits, Electrophoresis Reagents, Microarray Kits, Genotyping Assay Kits, Target Enrichment Kits, Nucleic Acid Labeling Kits
2) By Instruments: DNA Sequencers, PCR Machines, Microarray Scanners, Electrophoresis Systems, Real-Time PCR Systems, Automated Sample Preparation Systems, Genetic Analyzers, Bioanalyzers, Fragment Analyzers, Next-Generation Sequencing (NGS) Platforms
3) By Software: Data Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Genomic Data Interpretation Software, DNA Sequence Alignment Tools, Variant Annotation Software, Clinical Decision Support Software, Cloud-Based Genomic Platforms, Workflow Management Software, Data Visualization Tools
How Are Trends Impacting The Genetic Analysis Market?
Leading companies operating in the genetic analysis market are concentrating on developing advanced solutions, such as genetic testing options, to facilitate preventive measures or prompt monitoring. Genetic testing solutions involve examining an individual’s DNA to identify changes or variations in genes that may be linked to certain health conditions or inherited traits. For example, in June 2023, Devyser, a Sweden-based company specializing in diagnostic kit development, launched Devyser LynchFAP and Devyser BRCA PALB2, two genetic testing solutions aimed at hereditary cancer. Devyser LynchFAP distinguishes itself by offering a complete solution for analyzing PMS2 and nine additional genes associated with hereditary colorectal cancer, effectively resolving the complex issue of differentiating PMS2 from its pseudogene PMS2CL. It represents the first commercial kit specifically designed for precise analysis of the PMS2 gene. Devyser BRCA PALB2 enables targeted detection of genetic variants in BRCA1, BRCA2, and PALB2, which are key genes linked to an increased risk of breast and ovarian cancer. Its user-friendly design allows for quick integration into lab workflows and supports the analysis of DNA from both blood and tumor samples within a single test.
Which Companies Are Expanding Their Footprint In The Genetic Analysis Market?
Major companies operating in the genetic analysis market are Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Quest Diagnostics Inc., Illumina Inc., PerkinElmer Inc., BioRad Laboratories Inc., Qiagen NV, Oxford Nanopore Technologies Plc, 23andMe Inc., ELITech Group, MyHeritage Ltd., Dante Labs Inc., AutoGenomics Inc., IntegraGen SA, Family Tree DNA, 24 genetics, Centrillion Biosciences Inc., DNA Worldwide Group Ltd., Genebase.
Read the full genetic analysis market report here:
https://www.thebusinessresearchcompany.com/report/genetic-analysis-global-market-report
How Is The Genetic Analysis Market Distributed Across Key Geographic Regions?
North America was the largest region in the genetic analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Genetic Analysis Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27295&type=smp
Browse Through More Reports Similar to the Global Genetic Analysis Market 2026, By The Business Research Company
Scanner Market Report 2026
https://www.thebusinessresearchcompany.com/report/scanner-global-market-report
Scanner Software Market Report 2026
https://www.thebusinessresearchcompany.com/report/scanner-software-global-market-report
Document Scanning Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/document-scanning-services-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model